MetLife Investment Management’s Harrow HROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$803K Buy
18,908
+530
+3% +$19.7K ﹤0.01% 1631
2026
Q1
$648K Sell
18,378
-164
-0.9% -$7.21K ﹤0.01% 1627
2025
Q4
$909K Hold
18,542
﹤0.01% 1483
2025
Q3
$893K Hold
18,542
﹤0.01% 1511
2025
Q2
$566K Buy
18,542
+95
+0.5% +$2.55K ﹤0.01% 1618
2025
Q1
$491K Sell
18,447
-461
-2% -$13.8K ﹤0.01% 1739
2024
Q4
$634K Buy
18,908
+1,026
+6% +$45.4K ﹤0.01% 1669
2024
Q3
$804K Hold
17,882
﹤0.01% 1516
2024
Q2
$374K Buy
17,882
+4,125
+30% +$61.7K ﹤0.01% 1891
2024
Q1
$182K Hold
13,757
﹤0.01% 2249
2023
Q4
$154K Hold
13,757
﹤0.01% 2380
2023
Q3
$198K Hold
13,757
﹤0.01% 2216
2023
Q2
$262K Buy
+13,757
New +$303K ﹤0.01% 2106

Other funds holding HROW

MetLife Investment Management's HROW Position: Q2 2026 in Review

MetLife Investment Management increased its Harrow (HROW) stake by 2.9% in Q2 2026, buying an estimated $19.7K and bringing the position to 18,908 shares worth $803K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

MetLife Investment Management first reported a position in HROW in Q2 2023 and has held it in 13 quarters since. The position peaked at $909K in Q4 2025. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

  • MetLife Investment Management held 18,908 shares of Harrow worth $803K as of Q2 2026.
  • MetLife Investment Management bought 530 Harrow shares in Q2 2026, an estimated $19.7K.
  • Harrow made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1631 holding.
  • MetLife Investment Management first reported a position in Harrow in Q2 2023 and has held it in 13 quarters since.
  • MetLife Investment Management's Harrow position peaked at $909K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.